Skip to content

Role of Homoeopathy in Primary Dysmenorrhoea

Role of Homoeopathy in Primary Dysmenorrhoeaâ?? A Randomized Placebo Control Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/014949
Enrollment
60
Registered
2018-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Female patient who suffering from Primary Dysmenorrhoea (painful menses) Health Condition 2: N944- Primary dysmenorrhea

Interventions

Intervention1: indicated Homoeopathic medicine: different indicated medicine in primary dysmenorrhoea, Dose and Frequency-The doses varied from patient to patient. Repetitions will be done according

Sponsors

Dr Poonam Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All the patients fulfilling case definition of Primary dysmenorrhoea. 2. All the patients presenting with symptoms of Primary dysmenorrhoea. 3. womenâ??s under age of 25 are included in my study. 4. Patients suffering from Primary dysmenorrhoea, willing to participate and taking treatment regularly and co-operating for regular follow-up had been included

Exclusion criteria

Exclusion criteria: 1. The patients not fulfilling the case definition of Primary dysmenorrhoea. 2. Patients who require emergency medical intervention. 3. Patient without written consent. 4. Immune-compromised patients. 5. Patients who not take medicine & follow up properly and not follow advice, diet and regimen.

Design outcomes

Primary

MeasureTime frame
1. To determine the efficacy and significance of homoeopathic medicines in the management of primary dysmenorrhoea. 2. To determine the list of medicines and the corresponding potencies frequently indicated in the management of primary dysmenorrhoeaTimepoint: 6 months

Secondary

MeasureTime frame
To observe change in quality of life at the end of treatment no apperance of primary dysmenorrhoea within 2 yrsTimepoint: 18 months

Countries

India

Contacts

Public ContactDr Poonam Singh

Tantia University Sri Gangangar

drnc20007@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026